Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00002303-M02 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00002303-M02, RRID:AB_669228
- Product name
- Mouse Monoclonal FoxC2 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A purified. FOXC2 (2H3)
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.
FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma.
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol.
FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.
Shimoda Y, Ubukata Y, Handa T, Yokobori T, Watanabe T, Gantumur D, Hagiwara K, Yamanaka T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Harimoto N, Katayama A, Hikino T, Sano T, Ogata K, Kuwano H, Shirabe K, Oyama T
BMC cancer 2018 May 25;18(1):597
BMC cancer 2018 May 25;18(1):597
FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
Imayama N, Yamada S, Yanamoto S, Naruse T, Matsushita Y, Takahashi H, Seki S, Fujita S, Ikeda T, Umeda M
Pathology oncology research : POR 2015 Jul;21(3):783-91
Pathology oncology research : POR 2015 Jul;21(3):783-91
The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma.
Zhu JL, Song YX, Wang ZN, Gao P, Wang MX, Dong YL, Xing CZ, Xu HM
Histopathology 2013 Jun;62(7):1038-48
Histopathology 2013 Jun;62(7):1038-48
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol.
Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW, Chen YH, Jan Y, Hsiao M, Chang TY, Liu YH, Jeng YM, Wu CH, Huang MT, Su YH, Hung MC, Chien MH, Chen CY, Kuo ML, Su JL
Oncogene 2013 Jan 24;32(4):431-43
Oncogene 2013 Jan 24;32(4):431-43
FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.
Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M
Annals of surgical oncology 2011 Feb;18(2):535-42
Annals of surgical oncology 2011 Feb;18(2):535-42
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: FoxC2 Antibody (2H3) [H00002303-M02] - Western Blot analysis of FOXC2 expression in PC-12 ( Cat # L012V1 ).
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Sandwich ELISA: FoxC2 Antibody (2H3) [H00002303-M02] - Detection limit for recombinant GST tagged FOXC2 is approximately 0.3ng/ml as a capture antibody.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunocytochemistry/Immunofluorescence: FoxC2 Antibody (2H3) [H00002303-M02] - Analysis of monoclonal antibody to FOXC2 on HeLa cell. Antibody concentration 10 ug/ml.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: FoxC2 Antibody (2H3) [H00002303-M02] - Analysis of monoclonal antibody to FOXC2 on formalin-fixed paraffin-embedded human lateral ventricle wall. Antibody concentration 3 ug/ml.
